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Background: Indigenous Australians are significantly less likely to participate in colorectal cancer (CRC) screening
compared to non-Indigenous people. This study aimed to identify important factors influencing the decision to
undertake screening using Faecal Occult Blood Testing (FOBT) among Indigenous Australians. Very little evidence
exists to guide interventions and programmatic approaches for facilitating screening uptake in this population in
order to reduce the disparity in colorectal cancer outcomes.
Methods: Interviewer-administered surveys were carried out with a convenience sample (n = 93) of Indigenous
Western Australians between November 2009-March 2010 to assess knowledge, awareness, attitudes and
behavioural intent in regard to CRC and CRC screening.
Results: Awareness and knowledge of CRC and screening were low, although both were significantly associated
with exposure to media advertising (p = 0.008; p< 0.0001). Nearly two-thirds (63%; 58/92) of respondents reported
intending to participate in screening, while a greater proportion (84%; 77/92) said they would participate on a
doctor’s recommendation. Multivariate analysis with logistic regression demonstrated that independent predictors
of screening intention were, greater perceived self-efficacy (OR = 19.8, 95% CI = 5.5-71.8), a history of cancer
screening participation (OR = 6.8, 95% CI = 2.0-23.3) and being aged 45 years or more (OR = 4.5, 95% CI = 1.2-16.5). A
higher CRC knowledge score (medium vs. low: OR = 9.9, 95% CI = 2.4-41.3; high vs. low: 13.6, 95% CI = 3.4-54.0) and
being married or in a de-facto relationship (OR = 6.9, 95% CI = 2.1-22.5) were also identified as predictors of
intention to screen with FOBT.
Conclusions: Improving CRC related knowledge and confidence to carry out the FOBT self-screening test through
education and greater promotion of screening has the potential to enhance Indigenous participation in CRC
screening. These findings should guide the development of interventions to encourage screening uptake and
reduce bowel cancer related deaths among Indigenous Australians.Background
Indigenous Australians are at greater risk of death fol-
lowing a bowel cancer diagnosis compared to their non-
Indigenous counterparts due to higher rates of late stage
diagnoses of the disease [1]. Many of these deaths are
easily preventable through bowel cancer screening (also
known as colorectal cancer (CRC) screening) which can
detect bowel cancer in its early stages when the likeli-
hood of successful treatment is high [2,3]. In Australia, a* Correspondence: alikichristou@gmail.com
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lising Faecal Occult Blood Testing (FOBT) commenced
in 2006 providing free screening to all adults aged 50, 55
and 65 years. Further details and a brief history of the
Australian program are described in an earlier review [4]
and summarised in Table 1.
Regular population screening with the FOBT has been
shown to reduce mortality from bowel cancer [15,18,19],
however participation rates of Indigenous Australians
are less than half that of the general population [20].
These findings parallel CRC screening uptake rates in
Indigenous and ethnic minority groups around theed Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Table 1 Australia’s National Bowel Cancer Screening Program (NBCSP)
History and implementation
Australia is one of a few countries implementing a formal, government-funded, population-based CRC screening program. Others include the UK,
Canada, France, Italy and Finland and Japan [5]. Following a pilot program in 2002–2004, the first phase of Australia’s National Bowel Cancer
Screening program was rolled out in 2006 with free screening using FOBT offered to individuals turning 55 and 65 years of age. The second phase of
the program began in July 2008 and expanded eligibility to all people turning 50, 55 or 65 years. The program targets only specific age groups due
to limited funding and to ensure health services can cope with increased service demands [6]. However there are doubts about the evidence-base
upon which these decisions have been made [7]. Eligible participants are identified through Medicare (Australia’s national health insurance scheme)
enrolment and sent an invitation and FOBT screening kit to their home. After taking two consecutive samples of stool, individuals are required to
return the screening kit by post to the laboratory using a reply paid envelope provided [8]. Participants and their nominated doctor are then notified
of their result by mail recommendations made for follow-up if necessary. A bowel cancer screening register was established within Medicare to assist
in follow-up of positive tests not undergoing colonoscopies, re-screening of participants, and to aid data collection, monitoring and evaluation [6].
The data obtained are collected via forms filled in by the individual, their GP, colonoscopist and others. Completion of forms is not compulsory;
hence a large amount of information is incomplete or missing [9].
The screening test
The faecal occult blood test (FOBT) is a simple non-invasive self-screening test that detects small amounts of blood in the bowel motion. The FOBT is
the only screening test for CRC where evidence from randomised control trials (RCT) has demonstrated a reduction in mortality, although the trials
used the guaiac FOBT (gFOBT) as opposed to immunochemical FOBTs (iFOBT), the test used in Australia. A recently completed RCT using the iFOBT
demonstrated increased detection and compliance, although long-term mortality benefits have yet to be demonstrated [10].
Targeting the Indigenous population
In 2005/2006 it was announced that Indigenous people could participate in the NBCSP from the age of 45 years due to their earlier onset of bowel
cancer [11]. However, it is not clear whether FOBT kits are in fact being sent out to Indigenous people at this earlier age. Given that this would
require Indigenous status to be reliably identified on Medicare enrolment records, a large proportion of at-risk Indigenous people are likely to be
missing out on earlier screening.
Challenges and controversy surrounding the Program
The NBCSP has drawn much negative media attention which no doubt has influenced consumers’ opinions and created uncertainty regarding the
legitimacy and quality of test results. It has been described as a ‘piecemeal’ program that is inadequately funded, lacking resources and effective
communication strategies [12,13]. In 2009, nearly half a million testing kits were recalled and the program was temporarily suspended for six months
after an unusual decline in the number of positive test results, assumed to be due to faulty kits [7]. Testing resumed in November 2009 with a new
kit that was initially distributed to re-screen those who received the faulty kits and led to significant delays in rollout of the program. The new kit is
recommended for use only up to 30 degrees Celsius, creating potential problems for many regions, particularly in the north of Australia.
Funding and future of the Program
Initial funding for the Program was only secured up until June 2011 and the future of the program was uncertain for some time [12]. Substantial
lobbying and advocacy by community groups and several organisations led to a Government announcement in July 2011 to continue ongoing
funding of the program. In early May 2012, the Government committed to extending the program to those turning 60 years from 2013, and those
turning 70 in 2015 [14]. However, until 2017 the program will remain as it is, allowing for once-off testing of the population, even though the
mortality benefit associated with screening depends participation in regular screening [15]. According to the new announcement, full
implementation including biennial screening as recommended by clinical guidelines and supported by research [3,16], will be introduced in a
phased process from 2017 for all Australians aged 50 to 74. Such a fully implemented program can save lives - potentially preventing up to 500
deaths per year, and would cost the Australian Government an additional $50 million per year [17].world, which are also disproportionately lower than
mainstream populations [21-25].
Evidence from other cancer screening programs in
Australia indicate that lower participation of Indigenous
people results from a multitude of structural, socio-
cultural and behavioural factors, including shame and
fear regarding cancer, culturally insensitive services, poor
literacy, distance and access barriers, and low levels of
knowledge and awareness of the cancer, the screening
tests available, and associated benefits of screening [26].
To successfully create targeted messages and educa-
tional resources, and to inform interventions aimed at
enhancing screening participation, requires understand-
ing of the current knowledge, attitudes and beliefs of the
community of interest. To date there have not been any
peer-reviewed studies investigating the knowledge and
attitudes of Indigenous Australians towards bowelcancer screening, and the factors influencing the deci-
sion to engage in screening utilising FOBT.
Determinants of screening participation have been
examined in the context of health behaviour theories
such as the Health Belief Model [27] which provides a
framework in which to study the relationship between
an individual’s perceptions and beliefs about a disease,
and their decision of whether to engage in a preventive
health behaviour. Perceptions of personal susceptibility
to, and perceived severity of the disease, belief in one’s
ability to undertake a preventive action (perceived self-
efficacy), the potential benefits of, and perceived barriers
to undertaking this behaviour, all influence an indivi-
dual’s decision to partake in a preventive action. Atti-
tudes are also influenced by demographic and other
structural or socio-psychological factors. This model
purports that a cue to action must occur to trigger aChristou and Thompson BMC Public Health 2012, 12:528 Page 2 of 16
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behavioural change; this may result from a doctor’s
recommendation, media advertisement or an interven-
tion. Several studies have used health belief theories to
understand and identify factors associated with screen-
ing compliance [28-31]. By taking a similar approach,
this study aimed to elucidate factors that may be asso-
ciated with CRC screening intention. We present find-
ings from a baseline survey that was conducted as part
of an intervention study to assess the current knowledge,
attitudes and behavioural intentions of Indigenous West-
ern Australians in relation to bowel cancer and screen-
ing with FOBT. This information is critical for
identifying specific areas for intervention, and focus for
health promotion and education, to improve uptake of
CRC screening and reduce disparities in bowel cancer
outcomes for Indigenous Australians.
Methods
Study participants and data collection
Participants were recruited from two regional and one
metropolitan site in Western Australia through commu-
nity and family networks of health professionals known
to the researchers. Recruitment occurred between No-
vember 2009-March 2010 with assistance from Aborigi-
nal staff employed in Aboriginal-specific health services.
Eligibility criteria included self-identification as Aborigi-
nal or Torres Strait Islander, aged 35 years or more, and
the provision of written informed consent prior to par-
ticipation. Questionnaires were administered at face-to-
face interviews and participants received $20 to compen-
sate for time and travel expenses. An Indigenous refer-
ence group assisted with all aspects of the study. The
Western Australian Aboriginal Human Information and
Ethics Committee (250 08/09) and the Curtin University




The questionnaire measured respondent’s knowledge,
attitudes, beliefs and behaviours related to the preven-
tion, early detection and treatment of bowel cancer. The
instrument was adapted and further developed from sur-
veys identified in relevant literature, as no existing vali-
dated questionnaire was found that examined these
elements in Indigenous Australians for any cancer
screening modality. We favoured items from surveys
used with minority and/or Indigenous populations and
which were guided by key elements of the Health Belief
Model [32,33]. Items were also adapted from the know-
ledge, attitudes and practices (KAP) survey conducted
on the general Australian population prior to the
NBCSP pilot [34]. Before implementation, the question-
naire was piloted on a small group of Aboriginal peopleto ensure understanding and cultural appropriateness,
and modified accordingly.
Measures
The survey examined awareness of bowel cancer and
bowel cancer screening (if they had heard about the dis-
ease or the screening test/program and to describe what
they knew) and general knowledge and recognition of
risk factors and signs and symptoms of bowel cancer. A
knowledge score was computed for each respondent
based on 18 knowledge items with scores representing
the number of correctly answered items. For analysis,
scores were divided into tertiles of low (0-11), medium
(12-15) and high (16-18). These cut-off points were
selected based on dividing our sample population in al-
most equal thirds so that each third contained roughly
the same number of cases. As responses were distributed
towards greater knowledge with very few participants
having a score less than 6, it was not appropriate to div-
ide the total score based upon being one third of the
range (i.e. 0-6, 7-12, 13-18). Respondents in the bottom
third were considered to have lowest knowledge, the
middle third as medium knowledge, and top third as
high knowledge.
Screening behaviour was determined indirectly by ask-
ing respondents about their intention to participate in
bowel cancer screening (‘Would you consider doing an
FOBT bowel cancer screening test in the next 6-
12 months if a screening kit was given or sent to you?’),
and if they would take up screening following a doctor’s
recommendation. Attitude measures included percep-
tions of personal susceptibility to (‘Do you believe you
are at risk of getting bowel cancer?’) and perceived sever-
ity of bowel cancer (‘Do you think bowel cancer can be
cured if found early?’), perceived self-efficacy (‘How
confident do you feel in your ability to do the FOBT
screening test?’), perceived benefits, barriers and motiva-
tors for bowel cancer screening, fatalistic attitudes (‘Get-
ting cancer is like being sentenced to death’) and
perceptions of shame (‘You would feel too ashamed if
you found out you had bowel cancer’).
Items presented in a statement format required
respondents to indicate whether they agreed or dis-
agreed, with response categories consisting of a five-
point Likert scale (1 = strongly disagree, 2 = disagree,
3 = agree, 4 = strongly agree, and 5 = don’t know). Where
the format of the question answer was yes, no or don’t/
know, the no and don’t know categories were combined
for bivariate and multivariate analyses.
Health-care seeking behaviour including past screen-
ing participation and subjective health status were
assessed, as was family or personal cancer experience
and exposure to media advertising on bowel cancerChristou and Thompson BMC Public Health 2012, 12:528 Page 3 of 16
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screening. Socio-demographic information was also col-
lected and included self-rated English reading ability.Statistical methods
Questionnaire data was analysed using statistical soft-
ware PASW statistics 17 (SPSS Inc., IBM Company, Chi-
cago, Ill., USA). Descriptive statistics were carried out
on all survey items. Bivariate analyses were conducted
using Chi-square or Fisher’s exact test (when Chi-square
assumptions were not met) to examine relationships be-
tween categorical variables. Responses were dichoto-
mised as described above for bivariate and multivariate
analyses. Binary logistic regression was used to explore
the relationship between intention to screen for bowel
cancer and variables showing associations at the p = 0.30
level or less in bivariate analyses to identify independent
predictors of screening intent. All variables showing
associations at the p = 0.30 level or less were included in
the first step of the logistic regression model. Variables
with ten or more missing responses were excluded, as
was the item measuring awareness that bowel cancer/
polyps can be asymptomatic, as this was included in the
calculation of the total knowledge score. As bowel can-
cer knowledge score was significantly related to per-
ceived self-efficacy, perceived susceptibility and having
participated in screening in the past in bivariate analyses,
all of these variables could not be included in the same
logistic regression model. Thus, two logistic regressions
were performed – one excluding these three variables
and another including them, but excluding the know-
ledge variable. Marital status was almost significantly
related to knowledge (p = 0.054) and initially retained in
both models, however was subsequently removed from
model 1 as it caused unstable odds ratios and wide con-
fidence intervals. Thus, the first model included 12 of
the 26 variables and the second included 10. A backward
step-wise approach using the default ‘enter’ method in
SPSS was utilised, removing variables from the model
that were non-significant until only variables with a
p <0.05 remained in the model.Results
Socio-demographic characteristics
A total of 93 participants were recruited for this study
(Table 2). Females were over-represented with less than
25% of respondents being male. The majority (47.8%)
were in the 45-54 year age group, around half (52.7%)
were married or living in de-facto relationships, 44% had
either completed senior high school or a post-school
qualification, and over half (56.7%) were unemployed or
not working. Most respondents were enrolled with Medi-
care but only 17% had private health insurance. English
was the primary language spoken at home for most(92.4%), with 28% rating their English reading ability as
poor-fair.
Health-care seeking behaviour, cancer experience and
screening history
Over 80% had a regular GP and had seen a doctor
within the past 12 months (Table 2). Half (50%) reported
having participated in any cancer screening in the past
2 years, and 15% had undergone a colonoscopy. Only
5.6% (5/90) of respondents reported ever having done a
FOBT/bowel screening test.
Awareness and knowledge of bowel cancer and FOBT
bowel cancer screening
General awareness
The majority (78%; 72/92) of respondents reported hav-
ing heard of bowel cancer, although of those, only 15%
(11/72) could give a correct description of any aspect of
bowel cancer (for example, ‘cancer of the bowel or di-
gestive system’). Less than a third were aware of what
polyps were (29%, 25/86) and only 19 of the 25 (76%)
who said they knew what a polyp was, were able to de-
scribe it correctly. A small proportion (14%, 13/90) of
respondents reported knowing what an FOBT/bowel
cancer screening test was, and even after being given a
detailed explanation and description of the FOBT
screening test,1 only 30% (27/91) said that they had
heard of this test (data not shown).
Those who had heard of bowel cancer before were 6.6
times more likely (X2 [1] = 7.1, p = 0.008) to have seen or
heard media advertising related to bowel cancer screening,
and those who had heard of the FOBT/screening test were
13 times more likely (OR=13.5, p< 0.0001) to have been
exposed to such media advertising (data not shown).
Knowledge of bowel cancer risk factors and signs and
symptoms
Responses to individual knowledge items including iden-
tification of risk factors and signs and symptoms are
detailed in Table 3. The risk factor identified least fre-
quently was having a close relative with bowel cancer,
with only 56% (52/93) of respondents recognizing this as
a risk, whereas 70% (65/93) were aware of excessive al-
cohol consumption as a risk factor. Most (87%, 81/93)
recognized bleeding from the bowel as a symptom of
bowel cancer, whilst more vague symptoms were less
likely to be identified. Importantly, only 57% (52/92)
were aware that bowel cancer could be asymptomatic.
Factors associated with bowel cancer knowledge
Composite knowledge scores ranged from 0-18 and the
mean knowledge score was 13.3 (median = 15, SD= 4.3,
n = 93). Knowledge was not related to demographic vari-
ables such as age, education or income. SignificantChristou and Thompson BMC Public Health 2012, 12:528 Page 4 of 16
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Table 2 Socio-demographic characteristics, subjective
health status, healthcare seeking behaviour, cancer
experience and screening history of study participants
Variable n %^
Gender (n = 93)
Male 22 23.7
Female 71 76.3





Marital status (n = 91)
Married or de-facto 48 52.7
Separated/divorced/widowed 12 13.1
Single 26 28.6
Unwilling to say 5 5.5
Highest education level (n = 90)
Senior high school or higher (12 years or more) 40 44.4
Some high school (8-11 years) 25 27.8
Primary school or less (7 years or less) 21 23.3
Don’t remember 4 4.4
Employment status (n = 90)
Employed full-time or part-time 34 37.8
Unemployed/unable to work/other 32 35.6
Home duties 19 21.1
Unwilling to say 5 5.5
Annual household income (n = 90)
Less than $20,000 42 45.2
$20,000-40,000 11 11.8
$40,000-60,000 13 14.0
Over $60,000 9 9.7
Unwilling to say 15 16.2
Has any dependants (n = 88)
No 40 45.5
Yes 48 54.5
Enrolled with Medicare (n = 90)
No/don’t know 3 3.3
Yes 87 96.7
Private health insurance (n = 90)
No/don’t know 74 82.2
Yes 16 17.8
Self-rated English reading ability (n = 91)
Poor-fair 25 27.5
Good-very good 42 46.2
Excellent 24 26.4
Table 2 Socio-demographic characteristics, subjective
health status, healthcare seeking behaviour, cancer
experience and screening history of study participants
(Continued)
Self-rated current health status (n = 90)
Poor-fair 43 47.8
Good-very good 46 51.1
Excellent 1 1.11
Has a regular GP (n = 88)
No/don’t know 13 14.8
Yes 75 85.2
Frequency of doctor visits (n = 91)
Couple of times a year or more 71 78.0
Once a year 5 5.1
Less than once a year 15 16.5
Last time saw a doctor (n = 90)
Less than one month ago 47 52.2
Between one month and one year ago 36 40.0
More than one year ago/can’t remember 7 7.8
Participated in any cancer screening in past 2 years (n = 89)
No/don’t know 44 49.4
Yes 45 50.6
Had a colonoscopy in the past (n = 91)
No/don’t know 77 84.6
Yes 14 15.4
Ever done FOBT/bowel cancer screening test? (n = 90)
No/don’t know 85 94.4
Yes 5 5.6
Knows someone in family with cancer (n = 91)
No/don’t know 39 42.9
Yes 52 57.1
FOBT-faecal occult blood test; GP- general practitioner.
^Percentage calculated from valid responses indicated in parentheses
adjacent to survey item.relationships existed between knowledge and having par-
ticipated in screening in the past or having undergone a
colonoscopy, frequency of doctor visits, and family ex-
perience of cancer. Exposure to media advertising bor-
dered on having a significant association with knowledge
of bowel cancer (p = 0.051). In addition, knowledge was
also related to perceived self-efficacy and perceived sus-
ceptibility (see Table 4).
Attitudes towards bowel cancer and screening
Perceived susceptibility to bowel cancer was low in our
sample with only one-third (32%, 29/91) believing they
might be at risk, and only 14% (13/92) reporting that
their chance of getting bowel cancer was either high or
very high (Table 5). Perceptions of severity indicated thatChristou and Thompson BMC Public Health 2012, 12:528 Page 5 of 16
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Table 3 Respondent’s knowledge of risk factors and signs
and symptoms of bowel cancer
Knowledge Item (n) % Yes or Agree^
Risk Factors
Being overweight (91) 82.4




Having other types of bowel disease (92) 77.2
Diet can contribute to bowel cancer (93) 76.3
Low levels of physical activity (92) 75.0
History of polyps (93) 74.2
Risk increases with age (92) 72.8
Drinking too much alcohol (93) 69.9
Both Aboriginal and non-Aboriginal people
are at similar risk (93)
69.0




Bleeding from the bowels (93) 87.1
Change in bowel habits such as diarrhoea/
constipation (92)
76.1
Loss of weight for no reason (91) 76.0
Persistent abdominal pain/cramps (93) 75.3
Unexplained tiredness or weakness (91) 71.4
Loss of appetite (92) 67.4
Bowel cancer can be present without any
symptoms (92)
56.5
FOBT- faecal occult blood test.
^Percentage calculated from valid responses.over three quarters (77%, 69/90) felt it was a serious dis-
ease agreeing with the statements, ‘If you had bowel cancer
your whole life would change’. Despite this, most (82%, 75/
92) believed ‘bowel cancer can be cured if found early’. Fa-
talistic attitudes prevailed among a large proportion of
respondents who agreed that getting bowel cancer was a
death sentence (42%, 39/92 ) and that nothing can be done
to prevent getting the disease (35%, 32/91). One quarter
(24%, 22/91) also reported feelings of shame associated with
a bowel cancer diagnosis. Only about half (53%, 49/92)
rated their confidence (perceived self-efficacy) to carry out
the FOBTas confident or very confident.
Generally, respondents agreed with most statements of
benefits associated with FOBT screening (data not
shown). The items respondents most frequently agreed
with in terms of barriers to screening were being afraid
to find out something is wrong (44%, 41/93) or finding
out they have cancer (39%, 35/91) and not understand-
ing how to do the test (36%, 34/93). Not having symp-
toms (31%, 29/91) or privacy to do the test (26%, 24/91)
were also reported as constraints by about a quarter ofrespondents. Not having an appropriate place to store
stool samples was an issue for substantial numbers of
participants (40%, 37/93), as was feeling well and not
having symptoms (31%, 28/93), having to mail the kit
back (29%, 27/93) and not having a family history of
bowel cancer (26%, 24/93).
Intention to screen with FOBT
Overall, 63% (58/92) of respondents reported they would
consider doing the FOBT screening test in the next
6-12 months if they received it (Table 6). Interestingly, a lar-
ger proportion said they would do the test if their doctor
recommended it (84%; 77/92). Those intending to complete
an FOBT test were significantly more likely to do a test if a
doctor recommended it, while those who said they would
not consider doing a test were more likely not to do a test
even if a doctor recommended it (X2 [1], n=92)= 30.6,
p< 0.0001), suggesting that those refusing to consider
FOBT screening remained unlikely to do so despite a doc-
tor’s recommendation (data not shown).
Factors affecting screening intention
Table 6 summarises the relationship between intention
to screen with FOBT and a number of socio-
demographic, knowledge and attitudinal variables.
Socio-demographic factors
Those who intended to participate in screening were
more likely to be married or in de-facto relationships
(OR= 5.96, 95% CI = 2.3-15.7), employed, (OR= 3.14,
95% CI = 1.2-8.6) have a higher income (OR=2.8, 95%
CI = 0.99-7.8), at least 8 years of education (OR= 2.6,
95% CI = 1.0-6.8), and have seen a doctor within the past
year (OR= 5.4, 95% CI = 0.98-29.6). Participation in
other types of cancer screening (OR= 3.8, 95% CI = 1.5-
9.6) and knowing a family member with cancer (OR=
2.7, 95% CI = 1.1-9.9) also increased the likelihood of
screening uptake. Those who had previously had a col-
onoscopy were nine times more likely (OR= 9.2, 95%
CI = 1.2-74.3) to consider screening.
Bowel cancer knowledge
A direct association was observed between bowel cancer
knowledge and intention to screen, with the proportion
intending to screen increasing as knowledge score
increased. Compared to those with a low knowledge
score, respondents with medium knowledge were 8.5
times (p< 0.0001) more likely to consider screening and
those with high knowledge score were nearly 10 times
(p< 0.0001) more likely to consider screening. Those
who were aware bowel cancer can be asymptomatic, and
that bowel cancer can be cured if found early, were also
significantly more likely to consider screening.Christou and Thompson BMC Public Health 2012, 12:528 Page 6 of 16
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Table 4 Variation in knowledge score according to socio-
demographic characteristics and selected attitudinal
variables
Bowel cancer knowledge score %








Gender (n = 93)
Male 31.8 (7) 13.6 (3) 54.5 (12) X2 = 4.5
Female 28.2 (20) 36.6 (26) 35.2 (25) p = 0.109
Age (n = 90)
Up to 44 years 29.2 (7) 37.5 (9) 33.3 (8) X2 = 1.1
45+ 28.8 (19) 27.3 (18) 43.9 (29) p = 0.601
Marital status (n = 86)
Married/de-facto 22.9 (11) 41.7 (20) 35.4 (17) X2 = 5.8
Widowed/divorced/
separated/single
39.5 (15) 18.4 (7) 42.1 (16) p = 0.054
Education (n = 90)
7 years or less
(primary school or less)
40.0 (10) 32.0 (8) 28.0 (7) X2 = 3.32
More than 7 years
(some high school
or more)
23.1 (15) 30.8 (20) 46.2 (30) p = 0.190
Annual Income (n = 75)
Less than $20,000 28.6 (12) 35.7 (15) 35.7 (15) X2 = 5.5
$20,000 or more 9.1 (3) 33.3 (11) 57.6 (19) p = 0.064
Self-rated English reading ability (n = 91)
Poor or fair 44.0 (11) 28.0 (7) 28.0 (7) X2 = 4.3
Good, very good
or excellent
22.7 (15) 31.8 (21) 45.5 (30) p = 0.116
Participated in any screening in last 2 years (n = 89)
No/don’t know 43.2 (19) 34.1 (15) 22.7 (10) X2 = 12.97
Yes 15.6 (7) 26.7 (12) 57.8 (26) p = 0.002*
Last time you saw a doctor (n = 89)
In the past year 23.2 (19) 31.7 (26) 45.1 (37) X2 = 12.79
A year ago or more 85.7 (6) 14.3 (1) 0 (0) p = 0.002*
Frequency of doctor visits (n = 91)
Once a year or less 42.3 (11) 25.0 (7) 5.4 (2) X2 = 12.34
Couple of times a
year or more
21.1 (15) 29.6 (21) 49.3 (35) p = 0.002*
Ever had a colonoscopy? (n = 91)
No/don’t know 33.8 (26) 32.5 (25) 33.8 (26) X2 = 11.05
Yes 0 (0) 21.4 (3) 78.6 (11) p = 0.004*
Seen or heard advertising about bowel cancer (n = 91)
No/don’t know 35.6 (21) 32.2 (19) 32.2 (19) X2 = 5.96
Yes 15.6 (5) 28.1 (9) 56.3 (18) p = 0.051
Knows someone in family with cancer (n = 91)
No/don’t know 46.2 (18) 30.8 (12) 23.1 (9) X2 = 12.6
Yes 15.4 (8) 30.8 (16) 53.8 (28) p = 0.002*
Table 4 Variation in knowledge score according to socio-
demographic characteristics and selected attitudinal
variables (Continued)
Perceived self-efficacy




44.2 (19) 32.6 (14) 23.3 (10) X2 =13.05
Confident-very
confident
14.3 (7) 30.6 (15) 55.1 (27) p = 0.001*
Perceived susceptibility
Thinks they are at risk of bowel cancer (n = 91)
No/don’t know 84.6 (22) 75.9 (22) 48.6 (18) X2 =10.37
Yes 15.4 (4) 24.1 (7) 51.4 (19) p = 0.006*
*Significant at 0.05.
^Percentage calculated from valid responses indicated in parentheses
adjacent to survey item.
X2 - Chi-square.Attitudes/perceptions
One of the most significant associations with screening
intention was perceived self-efficacy or confidence in
carrying out the self-screening test. Those who felt
confident or very confident were over 13 times more
likely to screen (OR= 13.4, 95% CI = 4.6-38.6). A greater
perceived risk was also related with intent to screen
(OR= 2.96, 95% CI = 1.1-8.3), as was perceived severity
but only for one of three items (Do you think bowel can-
cer can be cured if found early? OR=4.15, 95% CI = 1.4-
12.6). No significant association was observed between
having a fatalistic attitude or greater awareness of bene-
fits of screening. Those who did not perceive a bowel
cancer diagnosis to be shameful were five times more
likely to consider taking up screening (OR= 5.05, 95%
CI = 1.7-14.7).Multivariate analyses
The first multivariate logistic regression model which
excluded bowel cancer knowledge score, identified being
aged 45 or more, having greater perceived self-efficacy,
and having participated in screening in the past as inde-
pendent predictors of intention to screen with FOBT. In
the second model, bowel cancer knowledge score and
marital status remained significant independent predic-
tors of screening intent (Table 7).Discussion
This is the first published study to examine awareness,
knowledge, attitudes and behavioural intention in regard
to bowel cancer screening in the Indigenous Australian
population. Given significantly lower levels of CRC
screening participation by this population group, it is
critical to elucidate reasons behind lower uptake toChristou and Thompson BMC Public Health 2012, 12:528 Page 7 of 16
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Table 5 Attitudes/perceptions towards bowel cancer and
FOBT screening
Survey Item (n) %
Perceived susceptibility
Think they are at risk of bowel cancer (n = 91)
No/don’t know (62) 68.0
Yes (29) 32.0
Worried or concerned about getting bowel cancer in the future (n = 91)
No/don’t know (40) 44.0
Yes (51) 56.0
Chance of getting bowel cancer in the future (n = 92)
Very low-low (28) 30.4
Medium (20) 21.7
High-very high (13) 14.1
Don’t know/unsure (31) 33.7
Perceived self-efficacy
How confident do you feel in your ability to do the FOBT test? (n = 92)
Not confident at all (13) 14.1
Not very confident (16) 17.4
Somewhat confident (14) 15.2
Confident (32) 34.8
Very confident (17) 18.5
Fatalistic attitude
Getting cancer is like being sentenced to death (n = 92)
Disagree (40) 43.5
Agree (39) 42.4
Don’t know/unsure (12) 13.0
There is nothing you can do to stop yourself getting bowel cancer (n = 91)
Disagree (42) 46.2
Agree (32) 35.2
Don’t know/unsure (17) 18.7
Perceived severity
Do you think bowel cancer can be cured if found early? (n = 92)
No/don’t know (17) 18.5
Yes (75) 81.5
If you had bowel cancer your whole life would change (n = 90)
Disagree (12) 13.3
Agree (69) 76.7
Don’t know/unsure (9) 10.0
The thought of bowel cancer scares you (n = 91)
Disagree (7) 7.7
Agree (76) 83.5
Don’t know/unsure (8) 8.8
Shame
You would feel ashamed if you found out you had bowel cancer (n = 91)
Disagree (54) 59.3
Table 5 Attitudes/perceptions towards bowel cancer and
FOBT screening (Continued)
Agree (22) 24.2
Don’t know/unsure (15) 16.5
FOBT- faecal occult blood test.
^Percentage calculated from valid responses indicated in parentheses
adjacent to survey item.
Agree represents % of respondents who answered strongly agree or agree to
survey item.
Disagree represents % of respondents who answered strongly disagree or
disagree to survey item.ensure good evidence informs program policy makers in
the design of ongoing and future health interventions.
General awareness
This study indicates that among the population we
sampled, general awareness of CRC and CRC screening
was low. Most had heard about bowel cancer but were
not able describe any particular detail of what it was or
what polyps were, and the vast majority had not heard
of bowel cancer screening or the FOBT test. The evalu-
ation of Australia’s NBCS pilot program also showed
that inadequate understanding and awareness of bowel
cancer were major impediments to the participation of
Aboriginal people in bowel cancer screening [35].
Having seen media advertising on bowel cancer
screening was significantly associated with greater
awareness and higher overall bowel cancer knowledge
scores, consistent with findings reported by Schroy et al.
examining the effect of media on awareness [36]. Despite
this, media exposure was not an independent predictor
of screening intention among our respondents, suggest-
ing that although it has a critical role to play, it is insuf-
ficient on its own. Exposure to media promotions prior
to receiving a screening kit was found to be an import-
ant trigger for participation for Indigenous people in the
final evaluation of the NBCSP pilot program in 2002.
This suggests a pivotal role of mass media for public
education and raising the profile of bowel cancer [36]
and confirms the recommendations of its use to raise
awareness and ultimately facilitate screening participa-
tion in minority groups [37].
Bowel cancer knowledge
Knowledge of specific bowel cancer risk factors was rea-
sonable, with about two thirds or more of participants
identifying the main risk factors. However, that over half
of participants did not know bowel cancer can be
asymptomatic, suggests this is an important concept to
be emphasised in education and awareness campaigns.
Factors significantly associated with bowel cancer
knowledge included having participated in cancer
screening in the past, seeing a doctor more often, havingChristou and Thompson BMC Public Health 2012, 12:528 Page 8 of 16
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Survey item Total (n) % Yes (n)a OR (95% CI) p-value
Gender (n = 92)
Male 21 61.9 (13) 1 0.902
Female 71 63.4 (45) 1.07 (0.39-2.91)
Age in years^+ (n = 90)
Up to 44 24 54.2 (13) 1 0.277
45+ 66 66.7 (44) 1.69 (0.65-4.39)
Marital status^+ (n = 86)
Married or de-facto 48 81.3 (39) 5.96 (2.26-15.71) <0.0001*
Widowed/divorced/single 38 42.1 (16) 1
Employment status (n = 91)
Employed 34 79.4 (27) 3.14 (1.15-8.58) 0.022*
Not employed 49 55.1 (27) 1
Education (n = 90)
7 years or less (primary school or less) 25 48.0 (12) 1 0.043*
8 or more years (some high school or more) 65 70.8 (46) 2.62 (1.02-6.78)
Annual Income (n = 75)
Less than $20,000 42 57.1 (24) 1 0.048*
$20,000 or more 33 78.8 (26) 2.79 (0.99-7.84)
Self-rated English reading ability (n = 90)
Poor or fair 24 54.2 (13) 1 0.277
Good, very good or excellent 66 66.7 (44) 1.69 (0.65-4.39)
Last time you saw a doctor^+ (n = 89)
In the past year 82 68.3 (56) 5.39 (0.98-29.6) 0.047#*
Over a year ago 7 28.6 (2) 1
Frequency of doctor visits (n = 91)
Once a year or less 20 50.0 (10) 1 0.148
Couple of times a year or more 71 67.9 (48) 2.09 (0.76-5.7)
Participated in any cancer screening in past 2 years^ (n = 89)
No/not sure 44 47.7 (21) 1 0.003*
Yes 45 77.8 (35) 3.83 (1.53-9.6)
Self-rated current health status (n = 90)
Poor-fair 43 67.4 (29) 1 0.439
Good-excellent 47 59.6 (28) 0.71 (0.3-1.69)
Ever had a colonoscopy^+ (n = 91)
No/don’t know 77 58.4 (45) 1 0.014*
Yes 14 92.9 (13) 9.24 (1.15-74.28)
Seen media advertising on bowel cancer screening^+ (n = 91)
No/don’t know 59 57.6 (34) 1 0.100
Yes 32 75.0 (24) 2.20 (0.85-5.72)
Knows someone in family with cancer^+ (n = 90)
No/don’t know 38 50.0 (19) 1 0.025*
Yes 52 73.1 (38) 2.71 (1.12-6.56)
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Ever heard of bowel cancer before^+ (n = 91)
No/don’t know 20 45.0 (9) 1 0.048*
Yes 71 69.0 (49) 2.72 (0.99-7.5)
Ever heard of bowel cancer screening test^+ (prompted) (n = 90)
No/don’t know 63 57.1 (36) 1 0.027*
Yes 27 81.5 (22) 3.30 (1.11-9.83)
Aware bowel cancer/polyps can be asymptomatic (n = 90)
No/don’t know 40 50.0 (20) 1 0.016*
Yes 51 74.5 (38) 2.92 (1.21-7.07)
Bowel cancer knowledge+
Bowel cancer knowledge score (n = 92)
0-11 (Low) 26 26.9 (7) 1 X2[2]=20.3
12-15 (Medium) 29 75.9 (22) 8.50 (2.5-28.7)
16-18 (High) 37 78.4 (29) 9.80 (3.1-31.6) <0.0001*
Perceived self-efficacy^
How confident do you feel to complete FOBT test (n = 92)
Not confident-somewhat confident 43 34.9 (15) 1 <0.0001*
Confident-very confident 49 87.8 (43) 13.40 (4.6-38.6)
Perceived susceptibility^
Thinks they are at risk of bowel cancer (n = 91)
No/don’t know 62 56.5 (35) 1 0.035*
Yes 29 79.3 (23) 2.96 (1.06-8.3)
Perceived severity
Do you think bowel cancer can be cured if found early?^+ (n = 92)
No/don’t know 17 35.3 (6) 1 0.009*
Yes 75 69.3 (52) 4.15 (1.37-12.57)
The thought of bowel cancer scares you (n = 82)b
Disagree 7 57.1 (4) 1 0.703#
Agree 75 64.0 (48) 1.33 (0.28-6.40)
If you had bowel cancer your whole life would change (n = 80)b
Disagree 11 81.8 (9) 2.72 (0.55-13.5) 0.312#
Agree 69 62.3 (43) 1
Fatalistic attitude
Getting cancer is like being sentenced to death (n = 79)
Disagree 40 75.0 (30) 2.32 (0.89-6.03) 0.082
Agree 39 56.4 (22) 1
Shame
You would feel ashamed if you found out you had bowel cancer (n = 76)b
Disagree 54 77.8 (42) 5.05 (1.74-14.7) 0.003*
Agree 22 40.9 (9) 1
Table 6 Socio-demographic, knowledge and attitudes associated with intention to screen for bowel cancer with FOBT
(Continued)
Perceived benefits
Doing a bowel cancer screening test can reduce chance of dying from bowel cancer (n = 83)b
Disagree 6 66.7 (4) 1 1.0#
Agree 77 67.5 (52) 1.040 (0.18-6.06)
FOBT - faecal occult blood test. OR – odds ratio.
*Significant at p ≤ 0.05.
#Fisher’s Exact Test.
^Variables included in first step of Model 1 of multivariate logistic regression.
+Variables included in first step of Model 2 of multivariate logistic regression.
aRefers to percentage of respondents who answered yes to the screening intent item, Would you consider doing an FOBT/bowel screening test in the next 6-12 months?
bExcludes those who selected don’t know/unsure.a family or personal experience with cancer, having been
exposed to media advertising about bowel cancer screen-
ing, greater levels of perceived self-efficacy and perceived
susceptibility. Most of these factors are related to exposure
to experiences that facilitate greater cancer awareness and
knowledge, implying that knowledge can be gained and is
not necessarily determined by education, income or age.
Perceived susceptibility to bowel cancer
Perceived susceptibility to CRC was generally quite low,
with only a third of our sample believing they were at
risk despite the majority being aged over 45 years, and is
in line with findings elsewhere in the literature [32].
Greater perceived risk to a disease can in some cases beTable 7 Multivariate analysis# of predictors of intent to partic
Model 1 (excluding variable: bowel cancer knowledge score from the m
Predictor
Age (>44 years vs ≤44 years^)
Participated in screening in the past (yes vs no^)
Perceived self-efficacy (confident-very confident vs not confident^)
Model 2 (excluding the variables: perceived self-efficacy, perceived su
model) (n = 86)
Marital status (married vs unmarried^)
Bowel cancer knowledge score (overall)
Medium vs Low^
High vs Low^
OR- odds ratio; CI- confidence interval; FOBT- faecal occult blood test.
#Multivariate analysis using binary logistic regression with a backwards step-wise ap
using FOBT in the next 6-12 months if a kit was given or sent to you?’
^reference category.
*significant at 0.05.
The following variables were excluded from multivariate analyses due to:
1. High number of missing responses: Income, Shame, Perceived benefits, and Fatalis
2. p> 0.30 in bivariate analysis: Gender, Self-rated current health status, Perceived sev
whole life would change).
3. Taken into account in the total knowledge score variable, Aware bowel cancer/po
4. Bowel cancer knowledge score was excluded from Model 1 due to strong associat
screening in the past.
5. Perceived self-efficacy, perceived susceptibility and participated in screening in the p
score.
6. Self-rated English reading ability and Employment status excluded due to strong a
7. Frequency of doctor visits excluded due to high correlation with Last time saw doc
8. Education excluded due to high correlation with Marital status.
9. Marital status excluded from Model 1 due to unstable OR and wide CI.associated with more positive preventive behaviour [38]
and our study also showed that those with a greater per-
ceived risk were significantly more likely to consider
FOBT participation. However, perceived risk was not an
independent predictor of screening intention, supporting
the theory that despite being important in influencing
CRC screening behaviour, it requires other mediating
factors to have an effect [39].Intention to screen using FOBT
Intention to screen for bowel cancer was relatively high
among our respondents with almost two-thirds report-
ing they would undertake FOBT screening in the futureChristou and Thompson BMC Public Health 2012, 12:528 Page 11 of 16
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if they received a kit. This is much higher than the 17%
participation rate observed from the most recent report
of Australia’s NBCSP [9], but equivalent to that found in
a study of rural Australians and low-income, ethnically
diverse groups in the US [31,40]. An even greater pro-
portion of respondents said they would do the FOBT
test if their doctor recommended it - a response which
supports research that shows endorsement of screening
by a primary care practitioner can facilitate participation
[32,41,42]. These results suggest that doctors and pos-
sibly other trusted health providers have an important
role to play in encouraging screening adherence. It also
supports findings from the NBCSP evaluation which
demonstrated that Indigenous people needed extra sup-
port and encouragement to participate in CRC screening
[35].
Bivariate analyses indicated that intention to take up
FOBT screening was significantly higher among those
who were married or in de-facto relationships,
employed, had at least eight years of education, higher
income, and a history of undergoing cancer screening or
a colonoscopy. Existing research also shows that lower
CRC screening uptake is consistently observed among
those who are less educated and from lower income
groups, and those from non-English speaking back-
grounds [20,43-45]. In contrast with the literature, Eng-
lish reading ability was not related to screening intention
in our study [46], however, this measure was self-
reported. Moreover, respondents with greater overall
knowledge and awareness of bowel cancer and the
screening test, greater perceived self-efficacy and per-
ceived susceptibility to the disease were also more likely
to consider screening, as were those who personally
knew someone with cancer.
On multivariate analysis, significant predictors of
screening intention were, being aged 45 years or more,
having greater levels of perceived self-efficacy or confi-
dence in carrying out the FOBT, and past participation
in cancer screening. Past screening participation was
also demonstrated to be an independent correlate of
CRC screening uptake in several studies [29,47], and al-
though our research does not directly measure participa-
tion, intention to participate can provide some
indication of behaviour.
One of the strongest associations and independent
predictors of screening intention in our sample was per-
ceived self-efficacy. This is highly pertinent to the Aus-
tralian program as bowel cancer screening is entirely
based upon a self-screening kit delivered by post, which
in urban areas is to participant’s homes, although mail is
not delivered to homes in some rural and remote areas.
Self-efficacy has not been explored extensively in the lit-
erature as countries such as the US and UK promote al-
ternative methods for CRC screening such ascolonoscopy or sigmoidoscopy alongside FOBT. Feufel
et al [48] have shown that improved instructions accom-
panying self-screening FOBT tests can help facilitate ap-
propriate of test completion. This is particularly relevant
for Indigenous Australians who had a higher proportion
of incorrectly completed FOBT tests compared to the
general population [20].
In the second logistic regression model, bowel can-
cer knowledge and marital status remained inde-
pendent predictors of intention to screen. Knowledge
and awareness can be important determinants of
screening behaviour, as a greater understanding of a
disease, its risk factors and methods of prevention
affects an individual’s decision to participate in
screening. Lower knowledge levels are associated
with a lower perceived risk and poorer CRC screen-
ing adherence rates in studies with ethnic minorities
[32]. An Australian study also found that those born
overseas had poorer bowel cancer knowledge scores
compared to those born in Australia, with knowledge
a predictor of screening intent [42]. Our research
finds a strong relationship between bowel cancer
knowledge score and intention to screen for CRC,
with screening intention increasing with each increase
in knowledge tertile. This relationship was retained in
multivariable analyses and is line with other research
demonstrating knowledge to be a significant predictor
of bowel cancer screening uptake [29,47,49]. Enhan-
cing knowledge can also lead to more positive atti-
tudes towards the disease and reduce negative
perceptions, which could in turn impact positively on
screening uptake [49]. Health education and promo-
tion should therefore focus on improving overall
knowledge related to bowel cancer and screening as a
means to facilitate screening compliance.
Screening intent and fatalistic attitudes
Previous studies have reported associations between
screening intent and fatalistic attitude towards bowel
cancer [50,51], but this was not evident in our study
despite the large proportion of respondents posses-
sing a fatalistic attitude. Shame was strongly asso-
ciated with intention to screen in bivariate analyses
but was not an independent predictor of screening
intent. Concerns about shame and embarrassment
differed from those observed in studies of Latinos
[32], yet corroborated findings from other ethnic mi-
nority groups [52–54]. This shows the need for cul-
turally targeted education and screening promotion
campaigns to address the differing beliefs and views
towards bowel cancer screening that exist between
different cultural groups in order to deliver appro-
priate messages that are effective.Christou and Thompson BMC Public Health 2012, 12:528 Page 12 of 16
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Perceived benefits to screening
Most participants agreed with the benefits of CRC
screening, although this did not appear to influence
screening intent among our sample, and is unlikely to be
a successful focal point in prevention or education cam-
paigns. Similar findings have been observed in a study of
African Americans [28]. Why this is the case needs to be
explored in greater depth, but it may be related to not
understanding personal risk or that perceived barriers
have a larger impact on screening decisions.
Barriers to FOBT screening
Fear of finding out something is wrong or finding out
they had cancer were major barriers to FOBT screening
for over a third of our sample. This is similar to research
undertaken with Italian migrants in Australia that found
fear of cancer and finding out they have cancer were
major barriers to screening [53]. In the present study,
additional barriers related to the design of the screening
program and test method including the postal distribu-
tion, storage of samples, and lack of privacy in which to
do the test. The absence of symptoms and not having a
family history of bowel cancer were also reasons that
respondents felt discouraged them from screening.
Again, the concept of self-efficacy arose with ‘not knowing
what to do’ being reported by over a third of respondents
as a major reason they would not complete the screening
test. These barriers cannot be ignored and most are heav-
ily impacted by the way the screening program is designed
and delivered to the Australian population. Research into
test preferences for Indigenous people is an area that is
under-investigated and is warranted if screening rates for
bowel cancer are to be increased [55,56].
Limitations
Several limitations to this study must be noted. As our
sampling strategy was non-random, the results of this
study cannot be considered representative of all Indige-
nous Australians. Participants were recruited primarily
through respected community members working in
health settings and are therefore likely to be more health
connected, proactive in their health behaviour, better
informed about health issues and have greater exposure
to prevention messages. Furthermore, participants lived
in urban and regional centres so results may not reflect
the views of those living in very remote regions and living
traditional/nomadic lifestyles.
The over-representation of females limited our ability to
find differences in knowledge or intention to screen across
gender. The nature of gender relations in Aboriginal culture
may have influenced our ability to recruit male participants
as well as the fact that all researchers involved in data col-
lection and recruitment were female. The higher proportion
of females and persons unemployed or not working in thisstudy occurred because these groups are more likely to have
the time to take part.
Our main outcome measure was largely hypothetical,
asking participants on their future ‘intention’ to take up
CRC screening. Such questions may not translate or pre-
dict real life behaviours, so results need to be interpreted
with caution. Nevertheless, considering undertaking a
preventive behaviour is a first step towards behaviour
modification and therefore remains important.
Additionally, knowledge items from the survey were
based on recognition rather than recall, limiting how far
this information can be extrapolated. We felt that this
approach would elicit greater responses than recall on
its own, and it is more commonly used in studies with
ethnic and minority groups [32,33].
Finally, our small sample size was a major limitation
on the extent of analysis that could be conducted, and is
partially responsible for the wide confidence intervals
observed particularly in the multivariate analysis. Despite
these limitations, our results have generated important
information on Aboriginal views of bowel cancer and
bowel cancer screening in an otherwise unexplored area
of Indigenous health.Conclusions
Critical to developing interventions for addressing the
underutilisation of CRC screening among Indigenous
Australians is an understanding of the factors that influ-
ence or determine screening adherence. Our study iden-
tifies key areas of focus for future health promotion and
education strategies and provides policy makers an
insight into specific areas that need to be addressed in re-
gard to the way the program is currently being delivered.
Less than six percent of our sample reported having
completed an FOBT test which is surprising given that
the majority were in the age group targeted by the
NBCSP, and is substantially lower than what has been
reported from the NBCSP and lower than Indigenous
participation in other countries [9]. This may be a reflec-
tion of the inappropriate design of the program which is
not reaching those high risk age groups it is designed to
[4]. All respondents reported being enrolled with Medi-
care and should have successfully received a screening
kit if address details were up to date. A large proportion
of our sample were between 45-54 years of age and
according to a Cancer Council report [11], screening kits
were being targeted to Aboriginal people from the age of
45 years. It is also possible that the short time since the
NBCSP had operated in WA (beginning in 2007) and
the recall of kits in late 2009 may have contributed to
the low rate reported for having received a kit.
The design of national screening programs often do
not take into account the social and cultural diversity ofChristou and Thompson BMC Public Health 2012, 12:528 Page 13 of 16
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the population in which they are implemented. A recent
analysis of Australia’s NBCSP described several inequi-
ties in access to screening for Indigenous and minority
groups in relation to the way the program is designed
and disseminated to the public [4]. The postal distribu-
tion of the FOBT and requirement for individuals to
self-screen, means the decision to carry out the test at
home is made without health provider consultation. Our
study also showed that these are significant barriers to
screening participation. Inadequate consideration is
given to low literacy populations, and the finding that
self-efficacy is a major determinant of intention to
screen lends further support to this.
Our study also illustrates the importance of improving
individual’s knowledge on bowel cancer and confidence
to carry out the FOBT test as a means to facilitate CRC
screening uptake with FOBT among Indigenous commu-
nities. Health education strategies need to focus on dem-
onstrating how the test is done to increase potential
participants’ confidence levels, as well as informing com-
munity members of the risk factors and signs and symp-
toms, emphasising the absence of symptoms that can
occur with CRC. Our study also supports the role of the
media in raising awareness and knowledge on bowel
cancer screening and its potential as a mediator of
screening uptake. Greater media promotion can assist in
eliminating stigma and shame associated with talking
about an issue that may be a source of embarrassment
and sensitivity for many. The attention that comes with
having a celebrity or well respected community member
speak about cancer can also be beneficial and encourage
screening uptake [57,58].
Future studies should focus on targeting a larger co-
hort of Aboriginal people including those living in re-
mote and very remote regions whose views can differ
significantly from urban and regional populations. The
NBCSP was implemented in WA only two years prior to
this study, which meant that few participants had actu-
ally received an FOBT test kit making detailed explor-
ation of reasons for uptake or non-screening difficult.
Future research when the population is more familiar
with the screening program may provide greater clarity
of reasons impeding or facilitating uptake of screening.
Notes:
1 Explanation of FOBT given to respondents: ‘An FOBT
is a screening test for bowel cancer that is carried out on
healthy people with no symptoms. This test can pick up
tiny amounts of blood in a sample of your bowel motion
that you yourself may not notice. Blood in the stools is
one sign of bowel cancer. This test is posted to you in the
mail so that you can do it at home by yourself by taking
a small sample of two bowel motions using sticks pro-
vided in a kit. You then return this kit by mail to betested. After it is tested you and your GP are notified by
mail of your result. If your test is positive for blood then
it will need further investigation and you will be referred
to have a colonoscopy at the nearest hospital.’
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